A detailed history of St. Louis Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, St. Louis Trust CO holds 7,956 shares of ABT stock, worth $913,030. This represents 0.13% of its overall portfolio holdings.

Number of Shares
7,956
Previous 9,679 17.8%
Holding current value
$913,030
Previous $1.01 Million 9.75%
% of portfolio
0.13%
Previous 0.15%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$100.07 - $118.13 $172,420 - $203,537
-1,723 Reduced 17.8%
7,956 $907,000
Q1 2024

May 01, 2024

BUY
$109.52 - $120.96 $188,702 - $208,414
1,723 Added 21.66%
9,679 $1.1 Million
Q4 2022

Feb 03, 2023

SELL
$95.06 - $111.52 $40,400 - $47,396
-425 Reduced 5.07%
7,956 $873,000
Q3 2022

Nov 01, 2022

BUY
$96.76 - $112.03 $42,477 - $49,181
439 Added 5.53%
8,381 $917,000
Q2 2022

Aug 01, 2022

BUY
$102.07 - $123.37 $1,326 - $1,603
13 Added 0.16%
7,942 $863,000
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $39,450 - $48,107
-346 Reduced 4.18%
7,929 $938,000
Q4 2021

Feb 07, 2022

SELL
$115.53 - $141.46 $5.78 Million - $7.07 Million
-49,988 Reduced 85.8%
8,275 $1.16 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $5.82 Million - $6.43 Million
49,857 Added 593.11%
58,263 $6.88 Million
Q2 2021

Aug 06, 2021

BUY
$105.79 - $124.53 $1,375 - $1,618
13 Added 0.15%
8,406 $975,000
Q1 2021

Apr 27, 2021

BUY
$108.84 - $128.23 $1,306 - $1,538
12 Added 0.14%
8,393 $1.01 Million
Q4 2020

Feb 03, 2021

BUY
$105.0 - $114.42 $1,050 - $1,144
10 Added 0.12%
8,381 $917,000
Q3 2020

Oct 27, 2020

BUY
$91.64 - $111.29 $1,191 - $1,446
13 Added 0.16%
8,371 $911,000
Q2 2020

Aug 06, 2020

SELL
$76.57 - $98.0 $16,232 - $20,776
-212 Reduced 2.47%
8,358 $764,000
Q1 2020

May 04, 2020

BUY
$62.82 - $91.86 $879 - $1,286
14 Added 0.16%
8,570 $676,000
Q4 2019

Feb 05, 2020

BUY
$78.51 - $87.4 $1,020 - $1,136
13 Added 0.15%
8,556 $743,000
Q3 2019

Oct 30, 2019

BUY
$81.84 - $88.74 $1,145 - $1,242
14 Added 0.16%
8,543 $715,000
Q2 2019

Jul 30, 2019

BUY
$72.88 - $85.0 $1,020 - $1,190
14 Added 0.16%
8,529 $717,000
Q1 2019

May 10, 2019

BUY
$66.22 - $80.06 $993 - $1,200
15 Added 0.18%
8,515 $681,000
Q4 2018

Jan 31, 2019

BUY
$65.56 - $74.27 $917 - $1,039
14 Added 0.16%
8,500 $614,000
Q3 2018

Oct 31, 2018

BUY
$60.81 - $73.36 $912 - $1,100
15 Added 0.18%
8,486 $623,000
Q2 2018

Aug 07, 2018

SELL
$57.57 - $63.54 $402,068 - $443,763
-6,984 Reduced 45.19%
8,471 $516,000
Q1 2018

Apr 23, 2018

BUY
$56.27 - $63.62 $422,925 - $478,167
7,516 Added 94.67%
15,455 $926,000
Q4 2017

Jan 25, 2018

BUY
$53.68 - $57.47 $161,898 - $173,329
3,016 Added 61.26%
7,939 $453,000
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $236,599 - $264,069
4,923
4,923 $263,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track St. Louis Trust CO Portfolio

Follow St. Louis Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St. Louis Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on St. Louis Trust CO with notifications on news.